Latest Global Markets News

Templeton Emerging Markets Investment Trust (TEMIT) posted a robust 41.3% net asset value total return for FY2026, outpacing its benchmark and narrowing its share price discount, while maintaining dividends and expanding share buybacks.

Bio-Gene Technology has expanded its capital raise to $2.775 million through a share placement priced at 2.5 cents, attaching options exercisable at 3.5 cents pending shareholder approval.

Advanced Energy Minerals (ASX:AEM) is ramping up its Cap-Chat high purity alumina production, targeting 3,000 tpa by mid-2026 and planning to double capacity to 6,000 tpa by 2029 amid a forecast supply deficit and surging demand.

Critical Resources (ASX:CRR) has demonstrated a sulphur-free amorphous solid-state electrolyte with ionic conductivity and activation energy rivalling sulphide-based counterparts, potentially unlocking safer, more scalable solid-state battery manufacturing.

Bass Oil has landed a $3.5 million grant from the South Australian Government to fund a production pipeline for its 100% owned Kiwi gas project, aiming to connect it to Cooper Basin infrastructure and boost domestic gas supply by 2028.

Biome Australia has launched a multi-centre clinical trial for its proprietary probiotic BMB18, adding a prestigious Greek university to its research network and commencing recruitment within the expected timeline.

XReality Group (ASX:XRG) posts strong FY26 revenue and ARR growth, marking key milestones with its first commercial MR-1 mixed reality sale to the US Department of Defense and debut European contract with the Swedish Armed Forces.

CleanSpace Holdings expects modest revenue growth for FY26, hindered by product certification delays and global market challenges, while maintaining a strong cash position and preparing a new respirator launch.

Bio-Gene Technology has raised A$3.21 million to complete critical safety studies for its novel insecticide Flavocide and ramp up production of its natural insecticide Qcide, advancing its path to commercialisation in multiple global markets.

Mont Royal Resources has identified significant high-grade fluorspar mineralisation up to 39.8% CaF2 at its Mallard Prospect, located just 1.4km from the flagship Ashram Deposit in Québec. The discovery highlights expanding fluorspar potential amid tightening global markets and China's shift to net importer status.

Noxopharm has unveiled new data showing its Sofra technology dramatically boosts TLR8 activation, a key immune pathway, potentially reshaping cancer immunotherapy.

Australian Agricultural Company (ASX:AAC) defies North Queensland floods to deliver a 23% jump in operating profit, driven by strong beef pricing and herd valuation gains.